EUVIMEDEUVIMED entdecken
Open Access

Teaching an Old Drug a New Trick: Targeting Treatment Resistance in Genitourinary Cancers

Karina Aguilar, Anuj K Sharma, Tianyu Yang, Dipen Mehta, Chandramukhi S Panda, Vinata B Lokeshwar

Journal of Cellular Signaling · 2024

DOI: 10.33696/signaling.5.112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Signaling, 2024. Verfasst von Karina Aguilar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta University, Augusta, GA, 1410 Laney Walker Blvd., 30912, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the quest for improving the clinical outcome of patients with metastatic genitourinary cancers, including metastatic renal cell carcinoma (mRCC), the emphasis often is on finding new targeted therapies. However, two studies by Jordan et al. (Oncogenesis 2020) and Wang et al. (Cancer Cell Int 2022) demonstrate the feasibility of improving the efficacy of a modestly effective drug Sorafenib against mRCC by attacking a mechanism hijacked by RCC cells for inactivating Sorafenib. The studies also identified hyaluronic acid synthase -3 (HAS3) as a bonafide target of Sorafenib in RCC cells. The studies demonstrate that an over-the-counter drug Hymecromone (4-methylumbelliferone) blocks inactivation of Sorafenib in RCC cells and improves its efficacy against mRCC through the inhibition of HAS3 expression and HA signaling. In the broader context, improving the efficacy of “old and failed drugs” that have favorable safety profiles should increase the availability of effective treatments for patients with advanced cancers.

Schlagwörter

Stichwörter der Autor:innen

Genitourinary cancerHAS3Hyaluronic acidHymecromone/4-methylumbelliferoneSorafenibUGT-1A9

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta University, Augusta, GA, 1410 Laney Walker Blvd., 30912, USA.

Förderung

  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Aguilar, K., Sharma, A. K., Yang, T., Mehta, D., Panda, C. S., & Lokeshwar, V. B. (2024). Teaching an Old Drug a New Trick: Targeting Treatment Resistance in Genitourinary Cancers. Journal of Cellular Signaling. https://doi.org/10.33696/signaling.5.112

Vancouver

Aguilar K, Sharma AK, Yang T, Mehta D, Panda CS, Lokeshwar VB. Teaching an Old Drug a New Trick: Targeting Treatment Resistance in Genitourinary Cancers. Journal of Cellular Signaling. 2024. doi:10.33696/signaling.5.112

BibTeX
@article{Aguilar2024,
  author = {Aguilar, Karina and Sharma, Anuj K and Yang, Tianyu and Mehta, Dipen and Panda, Chandramukhi S and Lokeshwar, Vinata B},
  title = {Teaching an Old Drug a New Trick: Targeting Treatment Resistance in Genitourinary Cancers},
  journal = {Journal of Cellular Signaling},
  year = {2024},
  doi = {10.33696/signaling.5.112}
}
Kostenlos starten →